Quantcast

Latest Rhinitis Stories

2009-08-07 05:46:00

NEW YORK, Aug. 7 /PRNewswire-Asia-FirstCall/ -- - Jingwei Capsules Treat Allergy Symptoms - - Complements Established Boke Nasal Spray Brand - - Diversifies Product Offering with Capsule Formulation - American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the...

2009-07-22 15:35:00

KENILWORTH, N.J., July 22 /PRNewswire-FirstCall/ -- Schering-Plough today announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed in the United States and accepted for review by the U.S. Food and Drug Administration (FDA). Schering-Plough is seeking marketing approval from the FDA of the mometasone furoate/formoterol fumarate combination for the maintenance treatment of asthma in patients 12 years of age and older....

2009-06-22 05:00:00

Asthma and allergy sufferers have an alternative to Singulair and Zicam - The ALCAT Test WARSAW, Poland, June 22 /PRNewswire/ -- Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular leukotriene blocking asthma and allergy drug, to upgrade their warning against psychotic side effects. Further respiratory distress was imposed on Zicam users when the FDA also last week announced warnings that the drug may cause a loss of smell. What's an...

2009-05-19 00:00:00

Schering-Plough Assumes Exclusive Worldwide Marketing Rights for Mometasone Furoate/Formoterol Combination for Asthma and COPD KENILWORTH, N.J., May 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced changes to its global collaboration with Novartis for the development and commercialization of fixed-dose combination therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The changes will result in Schering-Plough assuming...

2009-05-13 04:00:00

OXFORD, England, May 13 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated a phase II clinical development programme for its ragweed allergy therapy. The treatment for allergic rhino-conjunctivitis caused by ragweed pollen is based on Circassia's ToleroMune(R) technology, which has previously achieved successful phase II results in patients with cat allergies. Ragweed is one of the leading causes of allergic...

2009-05-11 02:00:00

LEEDS and LONDON, May 11 /PRNewswire/ -- - New Hayfever Relief Product Based on Acupressure Points Now Available in UK Stores & Widely Available on the Internet - With Photo Hayfever was unheard of only 200 years ago, however, it's believed that it now affects as many as 1 in 4 people in the UK. For those who do suffer with hayfever, it's either complete misery with symptoms such as reduced concentration, runny nose and itchy eyes throughout the day or the need for drug...

2009-05-04 13:01:00

Neti Pots Show Increase In Searches, Social Media "Chatter," As Consumers Seek Protection Ideas Above and Beyond CDC Recommendations MADISON, Wis., May 4 /PRNewswire/ -- Add nose washing to the steps that consumers are looking to take -- in addition to frequent hand washing and coughing in a tissue -- in an effort to avoid infection with the flu. According to data from Google Insights For Search, "neti pot" increased as a search term some 15-20% last week, with New York and California in...

2009-04-29 02:39:00

ANTONY, France, April 29 /PRNewswire-FirstCall/ -- Stallergenes S.A. announces the release of the first year outcome of its phase IIb/III clinical trial (VO 57.07) on a sublingual house dust mite desensitization tablet. "We are very pleased with the outcome of this study, which is the first large study to ever demonstrate the efficacy of house dust mites allergen in treating perennial allergic rhinitis. Furthermore, the unexpected quick onset of action and the good safety profile are...

2009-04-27 20:57:01

Children with allergies and asthma may benefit from an allergy evaluation, a U.S. allergist advises. Dr. Maya Jerath of the University of North Carolina at Chapel Hill School of Medicine says controlling allergy symptoms can prevent some of the common complications of untreated allergies like sinusitis and ear infections. Some sufferers seek relief with supplements like vitamin C or zinc, Jerath said. These supplements may help with colds, but there are no studies showing they work for...

2009-04-21 04:00:00

OXFORD, England, April 21 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced today that it has initiated a phase II clinical study of its ToleroMune(R) technology in allergy patients with asthma. The trial builds on positive phase II results that demonstrated the potential clinical benefits of ToleroMune allergy therapy, and extends clinical investigations to those with allergy-associated asthma. The lastest study, which is underway in...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.